Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

1.

DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.

Hou X, Peng JX, Hao XY, Cai JP, Liang LJ, Zhai JM, Zhang KS, Lai JM, Yin XY.

Ann Surg Oncol. 2014 Nov;21(12):3891-9. doi: 10.1245/s10434-013-3401-z. Epub 2013 Dec 4.

PMID:
24306662
2.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
3.

Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.

Nomoto S, Hishida M, Inokawa Y, Takano N, Kanda M, Nishikawa Y, Fujii T, Koike M, Sugimoto H, Kodera Y.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S443-50. doi: 10.1245/s10434-014-3581-1. Epub 2014 Mar 7.

PMID:
24604581
4.

Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.

Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.

J Surg Oncol. 2012 Mar 15;105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3.

PMID:
22052684
5.

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.

Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.

Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68. doi: 10.1002/gcc.20708.

PMID:
19760608
6.

Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.

Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Mar;31(3):1305-13. doi: 10.3892/or.2013.2939. Epub 2013 Dec 20.

PMID:
24366000
7.

Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.

Jung N, Won JK, Kim BH, Suh KS, Jang JJ, Kang GH.

J Korean Med Sci. 2012 Jun;27(6):594-604. doi: 10.3346/jkms.2012.27.6.594. Epub 2012 May 26.

8.

Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.

Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW.

World J Gastroenterol. 2015 Apr 7;21(13):3960-9. doi: 10.3748/wjg.v21.i13.3960.

9.

Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.

He G, Hu S, Zhang D, Wu P, Zhu X, Xin S, Lu G, Ding Y, Liang L.

Exp Mol Pathol. 2015 Oct;99(2):374-82. doi: 10.1016/j.yexmp.2015.06.017. Epub 2015 Jun 22.

PMID:
26112097
10.

Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.

Hu K, Wang J, Yao Z, Liu B, Lin Y, Liu L, Xu L.

Med Oncol. 2014 May;31(5):939. doi: 10.1007/s12032-014-0939-y. Epub 2014 Mar 30.

PMID:
24683008
11.

CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.

Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y.

Ann Surg Oncol. 2010 Jul;17(7):1917-26. doi: 10.1245/s10434-010-0921-7. Epub 2010 Jan 29.

PMID:
20112070
12.

Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.

Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK.

Ann Surg Oncol. 2013 Nov;20(12):3747-53. doi: 10.1245/s10434-013-3070-y. Epub 2013 Jun 26.

PMID:
23800896
13.

Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.

Zhang W, Zhou L, Ding SM, Xie HY, Xu X, Wu J, Chen QX, Zhang F, Wei BJ, Eldin AT, Zheng SS.

Oncol Rep. 2011 Apr;25(4):1053-62. doi: 10.3892/or.2011.1159. Epub 2011 Jan 24.

PMID:
21271221
14.

Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.

Gao S, Yang Z, Zheng ZY, Yao J, Zhang F, Wu LM, Xie HY, Zhou L, Zheng SS.

World J Surg Oncol. 2013 Mar 7;11:57. doi: 10.1186/1477-7819-11-57.

15.

Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.

Sueoka S, Kanda M, Sugimoto H, Shimizu D, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1453-60. doi: 10.1245/s10434-015-4524-1. Epub 2015 Mar 25.

PMID:
25805236
16.

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

Wang H, Jiang S, Zhang Y, Pan K, Xia J, Chen M.

World J Surg Oncol. 2014 Jul 18;12:226. doi: 10.1186/1477-7819-12-226.

17.

Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.

Ezaka K, Kanda M, Sugimoto H, Shimizu D, Oya H, Nomoto S, Sueoka S, Tanaka Y, Takami H, Hashimoto R, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1499-507. doi: 10.1245/s10434-015-4695-9. Epub 2015 Jun 30.

PMID:
26122373
18.

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.

Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ.

Oncotarget. 2016 Jan 26;7(4):4279-97. doi: 10.18632/oncotarget.6654.

19.

Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.

Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.

Clin Cancer Res. 2008 Nov 15;14(22):7405-12. doi: 10.1158/1078-0432.CCR-08-0409.

20.

Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.

Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.

Ann Surg Oncol. 2008 Dec;15(12):3494-502. doi: 10.1245/s10434-008-0146-1. Epub 2008 Oct 2.

PMID:
18830757

Supplemental Content

Support Center